BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37461041)

  • 21. Bioinformatic analysis of hub markers and immune cell infiltration characteristics of gastric cancer.
    Li C; Yang T; Yuan Y; Wen R; Yu H
    Front Immunol; 2023; 14():1202529. PubMed ID: 37359529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
    Li J; Zou X
    Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer.
    Wang J; Xia W; Huang Y; Li H; Tang Y; Li Y; Yi B; Zhang Z; Yang J; Cao Z; Zhou J
    Front Immunol; 2022; 13():1016612. PubMed ID: 36505458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer.
    Yin L; Feng S; Sun Y; Jiang Y; Tang C; Sun D
    J Gastrointest Oncol; 2022 Oct; 13(5):2234-2248. PubMed ID: 36388685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer.
    Wei J; Zeng Y; Gao X; Liu T
    BMC Cancer; 2021 Nov; 21(1):1221. PubMed ID: 34774009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance and biological function of transcriptional repressor GATA binding 1 in gastric cancer: a study based on data mining, RT-qPCR, immunochemistry, and vitro experiment.
    Wu H; Huang Z; Huang M; Dang Y; Lu H; Qin X; Liang L; Yang L; Ma J; Chen G; Lv Z
    Cell Cycle; 2020 Nov; 19(21):2866-2885. PubMed ID: 33044891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
    Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
    Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prognostic gene signature for gastric cancer and the immune infiltration-associated mechanism underlying the signature gene, PLG.
    Shi H; Duan J; Chen Z; Huang M; Han W; Kong R; Guan X; Qi Z; Zheng S; Lu M
    Clin Transl Oncol; 2023 Apr; 25(4):995-1010. PubMed ID: 36376702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients.
    Cao W; Zhou W; Li M; Zhang Z; Zhang X; Yang K; Yang S; Cao G; Chen B; Xiong M
    Front Immunol; 2022; 13():951135. PubMed ID: 36483555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients.
    Yuan M; Jia Y; Xing Y; Wang Y; Liu Y; Liu X; Liu D
    Front Genet; 2022; 13():965033. PubMed ID: 36186426
    [No Abstract]   [Full Text] [Related]  

  • 32. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
    Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
    Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the Correlation Between
    Gu X; Shen H; Xiang Z; Li X; Zhang Y; Zhang R; Su F; Wang Z
    Pharmgenomics Pers Med; 2023; 16():519-535. PubMed ID: 37284492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
    He XY; Zhao J; Chen ZQ; Jin R; Liu CY
    Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
    Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
    Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Key Genes and Circular RNAs in Human Gastric Cancer.
    Hao S; Lv J; Yang Q; Wang A; Li Z; Guo Y; Zhang G
    Med Sci Monit; 2019 Apr; 25():2488-2504. PubMed ID: 30948703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.
    Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D
    BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells.
    Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G
    Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.